Llibre JM, Brites C, Cheng CY, Osiyemi O, et al. Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With HIV-1: Week 48 Results From the Phase 3, Non-inferiority SALSA Randomiz Clin Infect Dis 2022 Mar 2. pii: 6541246. doi: 10.1093.
PMID: 35235656